Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FAS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FAS is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, interacts with. Associated with AD, ALS, AMI. Connected to 413 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | FAS |
| Protein Family | TNF receptor superfamily |
| Protein Type | Receptor |
| Function | FAS (also known as CD95 or APO-1) is a cell surface receptor that triggers apoptosis upon binding with its ligand FASLG |
| Primary Expression | neurons and glial cells throughout the brain and plays roles in developmental apoptosis, immune surveillance, synaptic pruning, a |
| Subcellular Localization | Plasma membrane |
| Molecular Weight | 43 kDa |
| Pathways | pathway: ### Activation Cascade |
| UniProt ID | P01375 |
| GeneCards | FAS |
| Human Protein Atlas | FAS |
| Associated Diseases | AD, Als, Alzheimer, Alzheimer's disease, AMI |
| Interactions | A2M, ACETYL-COA, AGING, AKT, ALS, ALZHEIMER |
| KG Connections | 601 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
FAS_gene["FAS
Gene"]
FAS_protein["FAS
Protein"]
FOXO["FOXO
Transcription Factor"]
AMBRA1["AMBRA1
Autophagy Regulator"]
apoptosis["Apoptosis
Cell Death"]
neurodegeneration["Neurodegeneration
Disease Process"]
neuroinflammation["Neuroinflammation
Immune Response"]
alzheimer["Alzheimer's
Disease"]
als["ALS
Disease"]
ms["Multiple
Sclerosis"]
TNF["TNF
Cytokine"]
IL6["IL6
Cytokine"]
APOE["APOE
Lipid Transport"]
inflammation["Chronic
Inflammation"]
aging["Cellular
Aging"]
senescence["Cellular
Senescence"]
FOXO -->|"activates"| FAS_gene
AMBRA1 -->|"regulates"| FAS_protein
FAS_gene -->|"encodes"| FAS_protein
FAS_protein -->|"activates"| apoptosis
FAS_gene -->|"activates"| neurodegeneration
FAS_gene -->|"activates"| neuroinflammation
FAS_gene -->|"activates"| alzheimer
FAS_gene -->|"activates"| als
FAS_gene -->|"activates"| ms
FAS_gene -->|"activates"| TNF
FAS_gene -->|"activates"| IL6
FAS_gene -->|"interacts_with"| APOE
FAS_gene -->|"regulates"| inflammation
FAS_gene -->|"regulates"| aging
FAS_gene -->|"regulates"| senescence
apoptosis -->|"contributes_to"| neurodegeneration
neuroinflammation -->|"promotes"| neurodegeneration
style FAS_gene fill:#006494
style FAS_protein fill:#006494
style AMBRA1 fill:#4a1a6b
style FOXO fill:#4a1a6b
style apoptosis fill:#ef5350
style neurodegeneration fill:#ef5350
style neuroinflammation fill:#ef5350
style alzheimer fill:#5d4400
style als fill:#5d4400
style ms fill:#5d4400
style inflammation fill:#ef5350
style aging fill:#ef5350
style senescence fill:#ef5350
style TNF fill:#ef5350
style IL6 fill:#ef5350
style APOE fill:#4a1a6b| Target | Relation | Type | Str |
|---|---|---|---|
| apoptosis | activates | phenotype | 0.90 |
| Lipid Metabolism | activates | pathway | 0.90 |
| Als | therapeutic_target | disease | 0.85 |
| Apoptosis | associated_with | process | 0.85 |
| Als | inhibits | disease | 0.85 |
| APOPTOSIS | promotes | process | 0.85 |
| Als | regulates | disease | 0.85 |
| Inflammation | activates | disease | 0.85 |
| cell death | promotes | process | 0.85 |
| Tumor | therapeutic_target | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Cancer | therapeutic_target | disease | 0.85 |
| dyslipidemia | drives | phenotype | 0.82 |
| Apoptosis | regulates | pathway | 0.80 |
| CANCER | therapeutic_target | gene | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Tumor | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Obesity | activates | disease | 0.75 |
| Diabetes | regulates | disease | 0.75 |
| Alzheimer | regulates | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Tumor | regulates | disease | 0.75 |
| Inflammation | inhibits | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| MITOCHONDRIA | activates | gene | 0.70 |
| BDNF | activates | gene | 0.70 |
| AKT | regulates | gene | 0.70 |
| MTOR | inhibits | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| GENES | regulates | gene | 0.70 |
| AKT | inhibits | gene | 0.70 |
| LC3 | inhibits | gene | 0.70 |
| AKT | activates | gene | 0.70 |
| BCL-2 | associated_with | gene | 0.70 |
| apoptosis | activates | process | 0.70 |
| LIPOPHAGY | inhibits | gene | 0.70 |
| Autophagy | inhibits | pathway | 0.70 |
| Lipid Metabolism | inhibits | pathway | 0.70 |
| Nf-Κb | inhibits | pathway | 0.70 |
| Mtor | inhibits | pathway | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| Heart Failure | contributes_to | disease | 0.65 |
| Fatty Liver | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Ischemia | contributes_to | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Cardiovascular | contributes_to | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AMBRA1 | regulates | protein | 0.90 |
| SREBP1C | upregulates | gene | 0.87 |
| FOXO | activates | protein | 0.80 |
| APOPTOSIS | regulates | gene | 0.80 |
| HSV-1 | regulates | entity | 0.75 |
| P53 | inhibits | gene | 0.70 |
| OXIDATIVE STRESS | activates | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| APOPTOSIS | associated_with | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| ALZHEIMER | regulates | gene | 0.70 |
| BAX | inhibits | gene | 0.70 |
| BDNF | activates | gene | 0.70 |
| IL6 | activates | gene | 0.70 |
| PI3K | regulates | gene | 0.70 |
| STAT3 | activates | gene | 0.70 |
| NF-ΚB | inhibits | gene | 0.70 |
| CYTOKINES | inhibits | gene | 0.70 |
| OXIDATIVE STRESS | inhibits | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | expressed_in | gene | 0.60 |
| TLR | activates | gene | 0.60 |
| TCR | regulates | gene | 0.60 |
| IL-6 | inhibits | gene | 0.60 |
| AUTOPHAGY | regulates | gene | 0.60 |
| DDB1 | therapeutic_target | gene | 0.60 |
| CD36 | expressed_in | gene | 0.60 |
| CAT | causes | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| STAT1 | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| BCL-2 | activates | gene | 0.60 |
| FASL | causes | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| TNF | treats | gene | 0.60 |
| APOE4 | associated_with | gene | 0.60 |
| P16INK4A | regulates | gene | 0.60 |
| IL6 | regulates | gene | 0.60 |
| CHMP4B | associated_with | gene | 0.60 |
| CHMP4B | regulates | gene | 0.60 |
| P21CIP1 | regulates | gene | 0.60 |
| ASTROCYTES | associated_with | gene | 0.60 |
| NEURON | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| ASTROCYTE | associated_with | gene | 0.60 |
| COMPLEMENT | expressed_in | gene | 0.60 |
| AGING | regulates | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Physiological SCFAs may confer indirect anti-synuclein benef | 0.670 | neurodegeneration | Do physiological concentrations of SCFAs |
| Physiological SCFAs may reduce alpha-synuclein burden primar | 0.650 | neurodegeneration | Do physiological concentrations of SCFAs |
| The most realistic translational use of physiological SCFAs | 0.610 | neurodegeneration | Do physiological concentrations of SCFAs |
| Physiological SCFAs may worsen alpha-synuclein pathology thr | 0.550 | neurodegeneration | Do physiological concentrations of SCFAs |
| Hippocampus ages transcriptionally faster than cerebellum, d | 0.516 | Alzheimer's disease | Allen Mouse Brain Aging Atlas: cross-age |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning FAS in their description or question text
No additional research found